The most recent trading session ended with Adma Biologics (ADMA) standing at $15.62, reflecting a -1.01% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which registered a loss of 0.18% for the day. Meanwhile, the Dow experienced a drop of 0.8%, and the technology-dominated Nasdaq saw an increase of 0.27%. Shares of the infectious disease drug developer have depreciated by 21.02% over the course of the past month, underperforming the Medical sector's loss of 3.03% and th ...